Prevention of Thromboembolic Events in Patients with COVID-19
| Published in: | TH Open |
|---|---|
| Main Authors: | Surbhi Warrior, Elizabeth Behrens, Joshua Thomas, Sefer Gezer, Parameswaran Venugopal, Shivi Jain |
| Format: | Article |
| Language: | English |
| Published: |
Georg Thieme Verlag KG
2021-07-01
|
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/a-1576-6201 |
Similar Items
Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19
by: V. A. Otdelenov, et al.
Published: (2020-10-01)
by: V. A. Otdelenov, et al.
Published: (2020-10-01)
PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH CANCER
by: Ju. A. Fedotkina
Published: (2019-06-01)
by: Ju. A. Fedotkina
Published: (2019-06-01)
Prevention of thromboembolic events in patients with atrial fibrillation – new anticoagulants
by: Alexandre Holthausen Campos, et al.
Published: (2011-09-01)
by: Alexandre Holthausen Campos, et al.
Published: (2011-09-01)
Prevention of venous thromboembolic events in ischemic stroke
by: Vladimir Anatolyevich Parfenov
Published: (2013-11-01)
by: Vladimir Anatolyevich Parfenov
Published: (2013-11-01)
Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients
by: Kristina Boss, et al.
Published: (2021-02-01)
by: Kristina Boss, et al.
Published: (2021-02-01)
Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19
by: Amer Hamadé, et al.
Published: (2021-03-01)
by: Amer Hamadé, et al.
Published: (2021-03-01)
Update on Thromboembolic Events After Vaccination Against COVID-19
by: Theocharis Anastasiou, et al.
Published: (2025-08-01)
by: Theocharis Anastasiou, et al.
Published: (2025-08-01)
PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)
by: A. V. Rudakova
Published: (2015-09-01)
PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)
by: A. V. Rudakova
Published: (2015-09-01)
Reply to :Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19
by: Amer Hamadé, et al.
Published: (2021-07-01)
by: Amer Hamadé, et al.
Published: (2021-07-01)
Thromboembolic events in hospitalised patients with COVID-19: ecological assessment with a scoping review
by: Tomoko Fujii, et al.
Published: (2023-01-01)
by: Tomoko Fujii, et al.
Published: (2023-01-01)
The Effectiveness of Compression Therapy in the Prevention of Venous Thromboembolic Complications in Patients With COVID-19
by: R. E. Kalinin, et al.
Published: (2022-10-01)
by: R. E. Kalinin, et al.
Published: (2022-10-01)
Thromboembolic Events in the Era of COVID-19: A Detailed Narrative Review
by: Maria Abou Mansour, et al.
Published: (2025-01-01)
by: Maria Abou Mansour, et al.
Published: (2025-01-01)
Cost-effectiveness of dabigatran for thromboembolic events prevention in atrial fibrillation patients in Chile
by: Tomás Abbot, et al.
Published: (2025-07-01)
by: Tomás Abbot, et al.
Published: (2025-07-01)
COVID-19 IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: THE RISK OF THROMBOEMBOLIC EVENTS AND CURRENT OPTIONS FOR ANTITHROMBOTIC PROPHYLAXIS
by: O.M. Kostiukevych, et al.
Published: (2022-10-01)
by: O.M. Kostiukevych, et al.
Published: (2022-10-01)
Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes
by: Rania Hammami, et al.
Published: (2022-01-01)
by: Rania Hammami, et al.
Published: (2022-01-01)
Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes.
by: Rania Hammami, et al.
Published: (2022-01-01)
by: Rania Hammami, et al.
Published: (2022-01-01)
Occurrence of acute coronary syndrome, pulmonary thromboembolism, and cerebrovascular event in COVID‐19
by: Yaser Jenab, et al.
Published: (2020-12-01)
by: Yaser Jenab, et al.
Published: (2020-12-01)
Efficacy and safety of rivaroxaban in prevention and therapy of thromboembolic events in patients with nonvalvular atrial fibrillation
by: Tamara Kovačević Preradovic, et al.
Published: (2023-01-01)
by: Tamara Kovačević Preradovic, et al.
Published: (2023-01-01)
The Impact of Prior Antithrombotic use
on Thromboembolic Events in Patients
with Cardiovascular Disease and Severe COVID-19 Infection
by: Amine Bouchlarhem MD, et al.
Published: (2022-12-01)
by: Amine Bouchlarhem MD, et al.
Published: (2022-12-01)
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
by: Raffaele De Caterina, et al.
Published: (2019-03-01)
by: Raffaele De Caterina, et al.
Published: (2019-03-01)
Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors
by: Alex C. Spyropoulos, et al.
Published: (2021-07-01)
by: Alex C. Spyropoulos, et al.
Published: (2021-07-01)
Thromboembolic events in people with cancer during the COVID-19 pandemic: case-control study
by: Vivian Cristina Gama Souza Lima, et al.
Published: (2024-08-01)
by: Vivian Cristina Gama Souza Lima, et al.
Published: (2024-08-01)
Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors
by: Harish Eswaran, et al.
Published: (2021-02-01)
by: Harish Eswaran, et al.
Published: (2021-02-01)
Increased Susceptibility for Thromboembolic Events versus High Bleeding Risk Associated with COVID-19
by: Cristina Tudoran, et al.
Published: (2022-08-01)
by: Cristina Tudoran, et al.
Published: (2022-08-01)
COVID-19 and Thromboembolic Events in the Pandemic and Pre-Pandemic Era: A Pediatric Cohort
by: Chiara Rubino, et al.
Published: (2023-07-01)
by: Chiara Rubino, et al.
Published: (2023-07-01)
Thromboembolism and Bleeding in COVID-19
by: Koray Durak
Published: (2021-08-01)
by: Koray Durak
Published: (2021-08-01)
Influence of thromboembolic events in the prognosis of COVID-19 hospitalized patients. Results from a cross sectional study.
by: Francisco Purroy, et al.
Published: (2021-01-01)
by: Francisco Purroy, et al.
Published: (2021-01-01)
Thromboembolic events in ß-Thalassemia major patients
by: Sawsan S. Abbas
Published: (2007-01-01)
by: Sawsan S. Abbas
Published: (2007-01-01)
Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19
by: Huong N. Q. Tran, et al.
Published: (2024-09-01)
by: Huong N. Q. Tran, et al.
Published: (2024-09-01)
Current and future immunotherapy for breast cancer
by: Natalie K. Heater, et al.
Published: (2024-12-01)
by: Natalie K. Heater, et al.
Published: (2024-12-01)
Prevention of venous thromboembolism in elderly patients
by: DING Mengxi, WANG Chunmei
Published: (2024-07-01)
by: DING Mengxi, WANG Chunmei
Published: (2024-07-01)
Inflammation and Venous Thromboembolism in Hospitalized Patients with COVID-19
by: Angelos Liontos, et al.
Published: (2023-11-01)
by: Angelos Liontos, et al.
Published: (2023-11-01)
P1687: THROMBOEMBOLISM IN COVID-19 PATIENTS ON ECMO
by: C. Jones, et al.
Published: (2022-06-01)
by: C. Jones, et al.
Published: (2022-06-01)
PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT
by: A. V. Rudakova
Published: (2015-09-01)
by: A. V. Rudakova
Published: (2015-09-01)
PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT
by: A. V. Rudakova
Published: (2015-09-01)
by: A. V. Rudakova
Published: (2015-09-01)
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study
by: Francesca Futura Bernardi, et al.
Published: (2023-10-01)
by: Francesca Futura Bernardi, et al.
Published: (2023-10-01)
Sex‐, Race‐ and Ethnicity‐Based Differences in Thromboembolic Events Among Adults Hospitalized With COVID‐19
by: Sadia Ilyas, et al.
Published: (2021-12-01)
by: Sadia Ilyas, et al.
Published: (2021-12-01)
Strategies for Diagnosis and Prevention of Venous Thromboembolism during Pregnancy
by: Shalini Jain Bagaria, et al.
Published: (2011-01-01)
by: Shalini Jain Bagaria, et al.
Published: (2011-01-01)
Prevention of thromboembolism in elderly
by: Panchanan Sahoo, et al.
Published: (2021-01-01)
by: Panchanan Sahoo, et al.
Published: (2021-01-01)
Similar Items
-
Possibility to use direct oral anticoagulants to prevent thromboembolic events in patients with COVID-19
by: V. A. Otdelenov, et al.
Published: (2020-10-01) -
PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH CANCER
by: Ju. A. Fedotkina
Published: (2019-06-01) -
Prevention of thromboembolic events in patients with atrial fibrillation – new anticoagulants
by: Alexandre Holthausen Campos, et al.
Published: (2011-09-01) -
Prevention of venous thromboembolic events in ischemic stroke
by: Vladimir Anatolyevich Parfenov
Published: (2013-11-01) -
Pathological findings in rotation thromboelastometry associated with thromboembolic events in COVID-19 patients
by: Kristina Boss, et al.
Published: (2021-02-01)
